New Japanese guidelines would allow for gene editing of human embryos for research purposes, according to Nature News.
Japan's science ministry wants a budget increase of about 20 percent, Science reports.
Japanese broadcaster NHK reports that a Japanese government panel has decided not to regulate some types of gene editing.
The firm's ROS1 gene fusion kit was approved as a companion diagnostic for Pfizer's Xalkori.
The Japan Times says regulations are needed to oversee human genome-editing research.
Japan needs to catch up on its gene-editing research efforts, the Japan News writes.
Japan is creating its first biosafety level-4 lab in response to concerns about the Ebola outbreak, Nature News reports.
The center, based in Yokohama, Japan, will likely purchase at least one single-molecule sequencer in order to avoid PCR-induced bias in Cap Analysis of Gene Expression, a method its researchers developed.
NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.
Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.
A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.
In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.